本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

天境生物

0.8550
+0.00981.16%
盘后0.8206-0.0344-4.02%18:26 EDT
成交量:10.40万
成交额:8.65万
市值:6,968.34万
市盈率:-3.12
高:0.8567
开:0.8070
低:0.8012
收:0.8452
数据加载中...
2021/03/29

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/01

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/09/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/14

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/07/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/29

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]